HYBRID LC-MS/MS FOR QUANTIFICATION OF INFLIXIMAB IN CROHN’S DISEASE PATIENT SAMPLES: DOES IT ADD VALUE? Caitlin M. Dunning1, Mary Lame1, Paula Orens1, Dominic Foley2, Ian Edwards1, Kelly Doering1, Jenny Leung3, Mark Ward4, Peter Irving5, and Zehra Arkir3 1 Waters Corporation,…
Key words
ifx, tracker, lisa, tnf, hybrid, digestion, infliximab, direct, sinsathyaesvk, patient, bablok, drug, elisa, assay, quantification